Sign in

CIK 0000921114

  • Non-accelerated filer
  • Smaller reporting company

Armata Pharmaceuticals, Inc.

Sign in to watch
Ticker
ARMP
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
Operating
EIN
911549568
Phone
+1 310-665-2928
Business address
5005 MCCONNELL AVE, LOS ANGELES, CA, 90066
Former names
AmpliPhi Biosciences Corp, TARGETED GENETICS CORP /WA/
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 1 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-01-10 Innoviva, Inc. Director Purchase · Convertible Debt convertible into Common Stock +0 $30,000,000.00 $0
2022-03-31 Innoviva, Inc. Director Purchase +5,385,208 $5.00 $26.9M 16,365,969
2022-03-31 Innoviva, Inc. Director Purchase · Warrants to Purchase Common Stock +0 $5.00 $0 2,692,604
2022-02-09 Innoviva, Inc. Director Purchase +3,614,792 $5.00 $18.1M 10,980,761
2022-02-09 Innoviva, Inc. Director Purchase · Warrants to Purchase Common Stock +1,807,396 $5.00 $9.0M 1,807,396
2021-10-29 Innoviva, Inc. Director Purchase +1,212,122 $3.30 $4.0M 7,365,969
2021-03-17 Innoviva, Inc. Director Purchase +4,285,935 $3.25 $13.9M 6,153,847
2021-03-17 Innoviva, Inc. Director Purchase · Warrants to Purchase Common Stock +4,285,935 $3.25 $13.9M 6,153,847
2021-01-26 Innoviva, Inc. Director Purchase +1,867,912 $3.25 $6.1M 1,867,912
2021-01-26 Innoviva, Inc. Director Purchase · Warrants to Purchase Common Stock +1,867,912 $3.25 $6.1M 1,867,912
2020-03-27 Innoviva, Inc. 10% owner Purchase +7,717,661 $2.87 $22.1M 8,710,800
2020-03-27 Innoviva, Inc. 10% owner Purchase · Warrants to Acquire Common Stock +7,717,661 $2.87 $22.1M 8,710,800

Page 1 of 1 · 12 trades